1 / 6

FY13 Priorities

FY13 Priorities. Avant-Garde (DP1) A- START (R03/$100K) IAS /NIDA Fellowship ($75K) Advancing exceptional HIV /AIDS Research (R01/RFA) Technology-Base Adherence Research (PA) NIDA Drug Abuse and HIV Cohorts (PAR/U01) Provide supplements for NIAID’s ACTG

sue
Télécharger la présentation

FY13 Priorities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FY13 Priorities • Avant-Garde (DP1) • A-START (R03/$100K) • IAS/NIDA Fellowship ($75K) • Advancing exceptional HIV/AIDS Research (R01/RFA) • Technology-Base Adherence Research (PA) • NIDA Drug Abuse and HIV Cohorts (PAR/U01) • Provide supplements for NIAID’s ACTG • OAR/NIDA/Russia and India Collaboration (R21) • Basic Biomedical (RFA/R01) (e.g., System Biology, Glia) • Novel Interventions PA (R34) • HIV, Drugs, & Vulnerable Pop PA (R21, R01)

  2. Avant-Garde Awardees FY 12 Jeremy Luban, M.D. University of Massachusetts, Medical School, Worcester David Smith, M.D. University of California, San Diego School of Medicine Samuel Friedman, Ph.D. National Development and Research Institutes, New York City Molecular epidemiology for HIV prevention for drug users and other risk groups Preventing HIV transmission by recently-infected drug users Human genes that influence HIV-1 replication, pathogenesis, and immunity in intravenous drug users

  3. AIDS-Science Track Award for Research Transition (A-START) • To facilitate the entry of new independent and early career investigators to the area of drug abuse research on HIV/AIDS • $100,000 per year, project duration of up to two years, non-domestic applicants are eligible

  4. Recent International AwardsNIDA Fellowship Awardees • Abagiu, Adrian- Romania(2011) • Ahmed, Munir- Bangladesh(2009) • Boci, Arian- Albania(2008) • Chtenguelov, Victor- India(2005) • Desai, NimeshG.- India(2008) • Dvoriak, Sergii- Ukraine (2006) • Isralowitz, Richard- Israel (2005) • Kader, Rehana- South Africa (2008) • Kasirye, R.- Uganda(2003) • Khin, Thanda- Burma(2010) • Malta, Monica- Brazil(2005) • Nurhidayat, Adhi- Indonesia(2008) • Otiashvili, David- Georgia(2011) • Piralishvili, Gvantsa- Georgia(2009) • PoudyalChhetri, Meen- Nepal(2008) • Simoes, Anna- Brazil(2005) • Telles–Dias, Paulo Roberto- Brazil (2011) • Toussova, Olga- Russia(2007) • Tsarouk, Tatiana- Russia(2006) • Vasilev, Georgi- Bulgaria(2010) • Zhao, Min- China(2005) • Zubaran, Carlos- Australia(2010)

  5. Topics Under Consideration • Cascade of Care Retention Gap • By Area, and risk group • Combination HIV Prevention Strategy • Implementation science approach • Alcohol, drug abuse, and HIV • Functional collaboration with NIAAA • Young minority MSM and prevention • Homeless/unstable housing • Integrating care: ID and addiction medicine

  6. WWW.DRUGABUSE.GOV/AIDS

More Related